Clinical Development

(Image: Getty/chombosan)

FT PHARMACEUTICAL & BIOTECHNOLOGY CONFERENCE

The danger of ‘going too far’ with AI

By Vassia Barba

Industry experts dealing with AI services should be showing both devotion to the possibilities opened and skepticism at the same time, says ICON exec.

Outsourcing-Pharma roundup October ‘19

People on the Move: Outsourcing-Pharma roundup October ‘19

By Melissa Fassbender

This month’s people on the move includes a new therapeutic lead at Advanced Clinical, with plans to create a network of investigation sites, as well as CEOs at AIT Bioscience and Pharm-Olam, who discuss plans for moving forward.

(Collaborative work in secondary packaging. Image credit: Vetter Pharma International GmbH)

Robots lend a hand in secondary packaging

By Melissa Fassbender

Vetter recently completed a successful pilot project to automate aspects of its secondary packaging series with the use of a dual-arm robot – which provides a high degree of continuity and precision, says CDMO.

(Image: Getty/ChristianChan)

Letter to the Editor

Counterpoint: 3 reasons Right to Try is less flexible than expanded access

By Richard Klein, director of expanded access programs and policy, GE2P2 Global Foundation

In a letter to the editor, Richard Klein, director of expanded access programs and policy for the GE2P2 Global Foundation, outlines three reasons why Right to Try is less flexible than expanded access.

Follow us

Products

View more

Webinars